Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Verrica Pharmaceuticals (VRCA) has provided an announcement.
Joe Bonaccorso has announced his resignation as the Chief Commercial Officer of Verrica Pharmaceuticals Inc., effective August 30, 2024. As part of his separation, he is set to receive a year’s base salary and potentially 12 months of paid health coverage. Furthermore, he will enter a consulting role with the company until August 2025, during which he will not receive cash compensation but will continue to vest in stock options and awards.
For detailed information about VRCA stock, go to TipRanks’ Stock Analysis page.
